Frontiers in Oncology (May 2023)

Metastasis in neuroblastoma: the MYCN question

  • Swapnil Parashram Bhavsar

DOI
https://doi.org/10.3389/fonc.2023.1196861
Journal volume & issue
Vol. 13

Abstract

Read online

Oncogenic drivers like MYCN in neuroblastoma subsets continues to present a significant challenge owing to its strong correlation with high-risk metastatic disease and poor prognosis. However, only a limited number of MYCN-regulatory proteins associated with tumor initiation and progression have been elucidated. In this minireview, I summarize the recent progress in understanding the functional role of MYCN and its regulatory partners in neuroblastoma metastasis.

Keywords